If you google Top Picks Euro Pacific Canada, the Canadian analyst Doug Loe has Neptune as a top pick for 2015 with a $7.50 PPS. The key though is to review each component of his analysis to see what you believe. Personally this is also my #1 bet in my IRA but I think he is optimistic. I don't believe we will see much action until the earnings begin to show the impact of the new plant. I will check back in a few months, no reason to sit around and watch the paint dry.
Hi team, so you are clear where I stand, this is my #1 investment for 2015. I recently retired and live off my investment income.(hopefully). I followed George Haywood from Sarepta to this stock. No pumping, just trying to make a living. :)
The Euro Pacific Canada analyst Doug Loe wrote this up as a 'top pick' for 2015 and here's what he had to say about the patent.
"Neptune’s US patents can potentially be a sizable profitability driver, but clear risk
to our patent royalty revenue until patent re-review concludes this quarter. While
on the subject of Neptune’s IP estate, we maintain our view that this patent, which
described medical uses for marine-derived omega-3 phospholipid esters, could
certainly stand up to further USPTO scrutiny if only because the Office clearly
believed at the time of original issuance that the claims therein were sufficiently
novel and non-obvious to support patentability. Furthermore, both Aker and
Enzymotec were sufficiently cautious on Neptune’s IP strength that they chose to
settle on the International Trade Commission investigation previously requested by
Neptune back in 2013, rather than to allow the investigation to proceed to